Deals
Receptos Said to Get M&A Interest Amid Partnership Talks
This article is for subscribers only.
Receptos Inc., the drugmaker that’s seeking a development partner for its multiple sclerosis treatment, is fielding takeover interest from potential buyers, people with knowledge of the matter said.
Receptos has been seeking a partner to develop ozanimod, which is a potential treatment for MS as well as inflammatory bowel disease. The partnership discussions, with as many as ten companies, led to the takeover interest, the people said.